Repatha (evolocumab) - Amgen, Astellas
EPOCH-LYSIS: Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke (clinicaltrials.gov) - Sep 11, 2026 - P2 | N=132 | Completed | Sponsor: The Affiliated Hospital of Xuzhou Medical University | Phase classification: P4 ➔ P2 
Phase classification • Atherosclerosis • Cardiovascular • Ischemic stroke
http://clinicaltrials.gov/ct2/show/NCT07301372
 
Sep 11, 2026
 
Prev Next